Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): Proof-of-concept trial
Objective: The TRIP proof-of-concept study examines functioning of the hippocampal DG/CA3 subregion as a biomarker and therapeutic target for memory impairment in Parkinson’s Disease (PD).…First Scientific Description of the Hepato-Lenticular Degeneration
Objective: Hepato-Lenticular Degeneration (HLD) first described by German pathologist Friedrich Theodor von Frerichs in 1854, but in the West it called Wilson's Disease. In Russia…Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson’s disease
Objective: To examine the characteristics of mild cognitive impairment in Parkinson’s disease (PD) patients with mild cognitive impairment (MCI) Background: Cognitive disturbances in PD detrimentally…The usefulness of a dual-phase 18-F-FP-CIT PET in a case of Alzheimer’s disease with slow movement
Objective: To think about the usefulness of a dual-phase 18-F-FP-CIT PET in cases of dementia with bradykinesia. Background: A classic 18-F-FP-CIT PET is useful in…The ADNPC-RS: a risk score that identifies Lewy body disease individuals at risk for developing concomitant Alzheimer’s pathology
Objective: To identify which common genetic variants that confer risk for Alzheimer’s disease (AD) also predict the development of concomitant AD pathology in patients with…Racial and Geographic Disparities in Parkinson’s Disease Patients with Gastrostomy Feeding Tube Placement
Objective: We sought to analyze a national database to examine how rates of gastrostomy tube (GT) placement in Parkinson's disease (PD) differ by race and…Significant hypometabolism in the posterior parietal cortex and precuneus in Parkinson’s disease with GBA mutations: [18F]FDG PET study
Objective: We explored [18F]FDG PET findings of PD patients with GBA mutation. Background: Parkinson’s disease (PD) with glucocerebrosidase (GBA) mutations is characterized by early onset…Prevalence of Neuropsychiatric Symptoms in the Prodromal Stages of Dementia with Lewy Bodies and Parkinson’s Disease Dementia
Objective: Investigate neuropsychiatric features of prodromal stage dementia among individuals diagnosed with Lewy body disease. Background: There has been minimal investigation into the prodromal features…Red blood cells alpha-synuclein heteroaggregates in the differential diagnosis of Lewy body dementias, Alzheimer’s disease and healthy controls
Objective: To investigate the diagnostic value of red blood cells (RBC) levels of total alpha-synuclein (α-syn), beta-amyloid (Aβ) 1-42, tau and its heteroaggregates in Lewy…The role of dementia in Parkinson’s disease
Objective: To identify cognitive and visual-spatial disorders in patients with Parkinson's disease. Background: In the clinical picture of Parkinson's disease, non-motor symptoms acquire great importance,…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 33
- Next Page »